Co-Diagnostics, Inc. Accretion Expense
Co-Diagnostics, Inc. (CODX) reported Accretion Expense of $91.43 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2021-03-25
- Co-Diagnostics, Inc. accretion expense for the quarter ending 2019-12-31 was $0.00.
- Co-Diagnostics, Inc. accretion expense for the quarter ending 2019-09-30 was $0.00.
- Co-Diagnostics, Inc. accretion expense for the quarter ending 2019-06-30 was $0.00.
- Co-Diagnostics, Inc. accretion expense for the quarter ending 2019-03-31 was $91.43K.
- Co-Diagnostics, Inc. accretion expense for fiscal 2019 was $91.43K.
- Co-Diagnostics, Inc. accretion expense for fiscal 2017 was $84.10K, a 290.88% increase from fiscal 2016.
- Co-Diagnostics, Inc. accretion expense for fiscal 2016 was $21.52K.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $0.00 derived: sum of 3 quarters · filed 2021-03-25 | $91.43K 10-K · filed 2021-03-25 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | $91.43K 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-11-03 | $91.43K 10-Q/A · filed 2020-11-03 | ||
| 2019-03-31 | $91.43K 10-Q · filed 2020-05-14 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $253.00 derived: sum of 2 quarters · filed 2019-04-01 | $42.19K derived: sum of 3 quarters · filed 2019-04-01 | $84.10K 10-K · filed 2019-04-01 |
| 2017-09-30 | $253.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $42.19K derived: sum of 2 quarters · filed 2018-11-14 | $84.10K 10-Q · filed 2018-11-14 | $92.43K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $41.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $83.85K 10-Q · filed 2018-08-10 | $92.18K derived: sum of 3 quarters · filed 2018-08-10 | $92.90K derived: sum of 4 quarters · filed 2018-08-10 |
| 2017-03-31 | $41.91K 10-Q · filed 2018-05-14 | $50.24K derived: sum of 2 quarters · filed 2018-05-14 | $50.96K derived: sum of 3 quarters · filed 2018-05-14 | |
| 2016-12-31 | $8.33K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $9.05K derived: sum of 2 quarters · filed 2018-03-28 | $21.52K 10-K · filed 2018-03-28 | |
| 2016-09-30 | $721.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $13.19K 10-Q · filed 2017-11-14 | ||
| 2016-06-30 | $12.46K 10-Q · filed 2017-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |